Form 8-K - Current report:
SEC Accession No. 0001193125-25-006578
Filing Date
2025-01-15
Accepted
2025-01-15 08:00:18
Documents
14
Period of Report
2025-01-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d830064d8k.htm   iXBRL 8-K 22432
5 GRAPHIC g830064g1028031449905.jpg GRAPHIC 2307
  Complete submission text file 0001193125-25-006578.txt   148041

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA biib-20250113.xsd EX-101.SCH 2859
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE biib-20250113_lab.xml EX-101.LAB 17235
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE biib-20250113_pre.xml EX-101.PRE 10818
16 EXTRACTED XBRL INSTANCE DOCUMENT d830064d8k_htm.xml XML 3477
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 25531203
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)